TQS 是 α7 烟碱乙酰胆碱受体正变构调节剂，可用于神经炎性疼痛的研究。

TQS is a positive allosteric modulator of α7 nACh receptors.

TQS reduces LPS-induced IκB and CD11b gene expression and microglial activation associated with hyperalgesia and allodynia by targeting microglial α7 nAChR in the hippocampus[1].

353483-92-8

C22H20N2O2S

376.47

4-Naphthalen-1-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide;TQS

DMSO:240 mg/mL (637.50 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years